CDKN2A and head and neck squamous cell carcinoma: In HPV(-) HNSCC, the cyclin D–CDK4/6–INK4–Rb pathway is impaired by amplification of CCND1 (20-30% of cases) and inactivation of p16INK4A (approximately 90% of cases) [1, 68].